Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Prié D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB.
Kormann R, et al. Among authors: jannot as.
Br J Haematol. 2017 Oct;179(2):323-335. doi: 10.1111/bjh.14842. Epub 2017 Jul 12.
Br J Haematol. 2017.
PMID: 28699644
Free article.
Clinical Trial.